Journal 2017-07-13T13:45:17+00:00
1202, 2016

Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials

By | February 12th, 2016|Categories: tipher|0 Comments

J. A. Davidson, D. D. Ørsted & C. Campos February 2016 and Posted June 2016 The aim of the present analysis was to evaluate the efficacy of the glucagon-like peptide-1 receptor agonist liraglutide in Latino/Hispanic [...]